Intravenous immunoglobulin [aapp, imft, phsu]
adjuvant therapy [topp]
Granulomatosis [dsyn]
Background [cnce]
Wegener Granulomatosis [dsyn]
WG [dsyn]
Necrotising vasculitis [dsyn]
Small vessel [bpoc]
Affect [menp]
Organ [bpoc]
body [humn]
Affect [menp]
Upper [spco]
Lower respiratory tract [bdsy]
Kidneys [bpoc]
Joints [bsoj]
Skin [bdsu]
Eyes [bpoc]
Current [tmco]
Remission Induction Therapy [topp]
Systemic [ftcn]
Corticosteroids [horm, phsu, strd]
Combination [qlco]
Oral [spco]
Daily [tmco]
Cyclophosphamide [opco, phsu]
Induce [ftcn]
Remission [fndg]
Cases [ftcn]
standard therapy [topp]
effective [qlco]
Inducing [ftcn]
Partial [qnco]
Complete Remission [fndg]
Complete Remission [fndg]
One [qnco]
Relapse [phpr]
objectives [inpr]
To [qlco]
If [qlco]
Intravenous immunoglobulin [aapp, imft, phsu]
adjuvant therapy [topp]
Therapeutic [topp]
treatment [ftcn]
Systemic [ftcn]
Corticosteroids [horm, phsu, strd]
Combination [qlco]
Immunosuppressants [imft, phsu]
treatment [ftcn]
WG [dsyn]
search [inpr]
strategy [menp]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
Searched [acty]
Trial [resa]
Last [qlco]
Searched [acty]
Central [spco]
Controlled [ftcn]
Trial [resa]
Library [mnob, orgt]
Last [qlco]
Searched [acty]
Issue [fndg]
Searched [acty]
MEDLINE [inpr]
Selection Criteria [qlco]
randomized controlled trials [inpr, resa]
randomized controlled trials [inpr, resa]
randomized [resa]
Cross-Over Trials [resa]
participants [popg]
To [qlco]
Adults [aggp]
confirmed [qlco]
Diagnosis [fndg]
WG [dsyn]
Data Collection [resa]
Analysis [lbpr]
Two [qnco]
Authors [prog]
Extracted [topp]
Data [idcn]
Assessed [acty]
Trial [resa]
Quality [qlco]
Relative Risk [qnco]
To [qlco]
Dichotomous [qlco]
variables [qlco]
Mean [qnco]
To [qlco]
Continuous [idcn]
variables [qlco]
Main [qlco]
Result [ftcn]
included [ftcn]
One [qnco]
participants [popg]
Assigned [ftcn]
To [qlco]
Receive [qlco]
Intravenous immunoglobulin [aapp, imft, phsu]
placebo [topp]
Once daily [tmco]
Azathioprine [orch, phsu]
prednisolone [phsu, strd]
Remission [fndg]
Maintenance [acty]
Adjuvant [chvf]
Intravenous immunoglobulin [aapp, imft, phsu]
Adjuvant [chvf]
placebo [topp]
Mortality [qnco]
Serious Adverse Event [fndg]
Time [tmco]
Relapse [phpr]
OPEN LABEL [resa]
therapy [ftcn]
Infection, NOS [dsyn]
Rate [acty]
Fall [fndg]
Disease [dsyn]
activity [dora]
Score [qnco]
Derived [qlco]
Patient symptoms [fndg]
Reported [inpr]
Slightly [idcn]
Intravenous immunoglobulin [aapp, imft, phsu]
Group [idcn]
placebo [topp]
Group [idcn]
One [qnco]
month [tmco]
Mean [qnco]
Confidence Interval [qnco]
P NOS [aapp, imft]
Three [qnco]
months [tmco]
Mean [qnco]
Confidence Interval [qnco]
P NOS [aapp, imft]
Increase [ftcn]
adverse events [fndg]
Intravenous immunoglobulin [aapp, imft, phsu]
Group [idcn]
Relative Risk [qnco]
Confidence Interval [qnco]
P NOS [aapp, imft]
Authors [prog]
Conclusions [idcn]
Insufficient [qlco]
Evidence [ftcn]
One [qnco]
Intravenous immunoglobulin [aapp, imft, phsu]
adjuvant therapy [topp]
Therapeutic [topp]
Compared [acty]
Combination [qlco]
Steroids [strd]
Immunosuppressants [imft, phsu]
Patients [podg]
WG [dsyn]
GIVEN [cnce]
High [qlco]
Cost [qnco]
Intravenous immunoglobulin [aapp, imft, phsu]
One [qnco]
Dose [qnco]
KG [geoa]
Limited [ftcn]
To [qlco]
TREAT [ftcn]
WG [dsyn]
Context [fndg]
Well [qlco]
Conduct [inbe]
powered [hcpp]
To [qlco]
detect [fndg]
Patient Outcome [idcn]
Relevant [qlco]
